Updates of incretin-related drugs for the treatment of type 2 diabetes.

Hirotaka ArakiTakeshi MatsumuraNoboru FurukawaEiichi Araki

Published in: Journal of diabetes investigation (2022)

Mechanisms of dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists and glucagon-like peptide-1 receptor/glucose-dependent insulinotropic polypeptide receptor dual-agonist in glycemic control and/or weight loss.

Keyphrases

glycemic control
weight loss
blood glucose
type diabetes
bariatric surgery
roux en y gastric bypass
gastric bypass
blood pressure
weight gain
smoking cessation